EPAS1 and hepatocellular carcinoma: Concerning HCC, growing evidence shows a correlation between HIF-2α expression and clinic-pathological features, including tumor grade, venous invasion, necrosis, intrahepatic metastasis, and capsule infiltration, with a significant increase of the overall survival rates of patients with HIF-2α-negative tumors.